Cargando…

Antihypertensive Effectiveness of Perindopril Arginine and Indapamide Single-Pill Combination According to Body Mass Index: Findings from the FORSAGE Study

INTRODUCTION: Overweight and obesity are increasing worldwide and are associated with an increased risk for cardiovascular disease (CVD). The aim of this study was to examine the burden of CVD risk factors among normal weight, overweight, and obese subjects with hypertension, and to evaluate the eff...

Descripción completa

Detalles Bibliográficos
Autor principal:	Glezer, M. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237592/ https://www.ncbi.nlm.nih.gov/pubmed/32008207 http://dx.doi.org/10.1007/s40119-020-00162-x

Ejemplares similares

Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
por: Borghi, Claudio, et al.
Publicado: (2023)

Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial
por: Nedogoda, Sergey V., et al.
Publicado: (2017)

Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational Studies
por: Farsang, Csaba, et al.
Publicado: (2021)

Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects
por: Mazza, Alberto, et al.
Publicado: (2019)

Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022)

UHPLC-UV Method for Simultaneous Determination of Perindopril Arginine and Indapamide Hemihydrate in Combined Dosage Form: A Stability-Indicating Assay Method
por: Al-Tannak, Naser F.
Publicado: (2018)

Correction to: Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022)

Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius
por: Mbanya, Armand, et al.
Publicado: (2022)

Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
por: Barrios, Vivencio, et al.
Publicado: (2010)

Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
por: Farsang, Csaba
Publicado: (2014)

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy
por: Asmar, Roland, et al.
Publicado: (2007)

Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial
por: Mourad, Jean-Jacques, et al.
Publicado: (2007)

Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials
por: Chalmers, John, et al.
Publicado: (2023)

The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension – a Post-marketing Study
por: Šukalo, Aziz, et al.
Publicado: (2022)

Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study
por: Mourad, Jean-Jacques, et al.
Publicado: (2008)

Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
por: Bulpitt, Christopher J, et al.
Publicado: (2006)

Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS/MS and its pharmacokinetic application
por: Tao, Yi, et al.
Publicado: (2018)

Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study
por: Jadhav, Uday, et al.
Publicado: (2014)

Effectiveness of indapamide/amlodipine single-pill combination in patients with isolated systolic hypertension: post-hoc analysis of the ARBALET study
por: Kobalava, Zh. D., et al.
Publicado: (2022)

Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical formulations
por: Duraisamy, Kalaiyarasi, et al.
Publicado: (2017)

Correction: Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study
Publicado: (2014)

The Influence of Microneedles on the Percutaneous Penetration of Selected Antihypertensive Agents: Diltiazem Hydrochloride and Perindopril Erbumine
por: Luu, Emmy, et al.
Publicado: (2018)

Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study
por: Fleig, Susanne V., et al.
Publicado: (2018)

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: Case report of severe multiorgan involvement to perindopril/amlodipine combination antihypertensive
por: Chan, Linda, et al.
Publicado: (2018)

Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study
por: Kobalava, Zhanna, et al.
Publicado: (2023)

Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy
por: Rea, Federico, et al.
Publicado: (2023)

Renoprotection with indapamide, additional feature to look for
por: Pande, Arindam
Publicado: (2017)

Chemical stability and interactions in a new antihypertensive mixture containing indapamide and dihydralazine using FT-IR, HPLC and LC-MS methods
por: Gumieniczek, Anna, et al.
Publicado: (2018)

Permeability of the Perindopril Arginine under In Vitro Conditions across Caco-2 Monolayer and Biomimetic Phospholipid Membrane
por: Kus, Marta, et al.
Publicado: (2022)

Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study
por: Boytsov, Sergey A., et al.
Publicado: (2021)

Correction: Chemical stability and interactions in a new antihypertensive mixture containing indapamide and dihydralazine using FT-IR, HPLC and LC-MS methods
por: Gumieniczek, Anna, et al.
Publicado: (2018)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Indapamide/potassium: Hypokalaemia and lack of efficacy: case report
Publicado: (2022)

Warfarin Dosing Requirement According to Body Mass Index
por: Alshammari, Abdullah, et al.
Publicado: (2020)

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite
por: Al Ali, Samer Hasan Hussein, et al.
Publicado: (2012)

Possible combined effect of perindopril and Azilsartan in an experimental model of dementia in rats
por: Alzahrani, Yahya M., et al.
Publicado: (2020)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Indapamide-induced transient myopia with supraciliary effusion: case report
por: Végh, Mihály, et al.
Publicado: (2013)

Physical Ageing of Amorphous Indapamide Characterised by Differential Scanning Calorimetry
por: Drogoń, Agata, et al.
Publicado: (2020)

Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations
por: Burnier, Michel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dqn76b257v7f76re0g0hbqbjm3